| Deler fremragende | 73,023,061 shares |
| Insideraktier | 6.770.877 shares |
| Insider ejerskab | 9,27 % |
| Total Insiders | 25 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Zymeworks Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| 667, L.p. Director - [D] | 9.000 | 3.248.692 | |
| Christopher Astle SVP & Chief Financial Officer - [O] | 670 | 670 | |
| Baker Bros. Advisors Lp Director - [D] | 3.248.692 | 3.248.692 | |
| Felix Baker Director - [D] | 9.000 | 3.248.692 | |
| Julian Baker Director - [D] | 9.000 | 3.248.692 | |
| Baker Bros. Advisors (GP) LLC Director - [D] | 9.000 | 3.248.692 | |
| Baker Brothers Life Sciences LP Director - [D] | 9.000 | 3.248.692 | |
| Nick Bedford Director - [D] | 274.446 | 274.446 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Troy Cox Director - [D] | 7.500 | 7.500 | |
| Kenneth Galbraith | 500.000 | ||
| Diana Hausman Chief Medical Officer - [O] | 5.377 | 5.377 | |
| Hillan Kenneth J. | 9.000 | ||
| Neil Josephson Chief Medical Officer - [O] | 14.449 | 14.449 | |
| Neil A Klompas Chief Operating Officer - [O] | 15.501 | 15.501 | |
|
Eli & Co Lilly
10% Owner -
|
2.898.647 | 2.898.647 | |
| Susan Mahony | 9.000 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Kelvin Neu | 0 | ||
| Kathryn O'Driscoll Chief People Officer - [O] | 6.350 | 6.350 | |
| Polverino Anthony J. Chief Scientific Officer - [O] | 36.407 | 36.407 | |
| David Kai Yuen Poon See Remarks - [O] | 0 | 0 | |
| James Priour Chief Commercial Officer - [O] | 2.513 | 2.513 | |
| Hollings Renton | 9.000 | ||
| Natalie Sacks | 9.000 | ||
| Ali Tehrani Chief Executive Officer, Director - [D] [O] | 260.325 | 260.325 | |
| Zoth Lota S. | 9.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ZYME / Zymeworks Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ZYME / Zymeworks Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | 2022-11-10 | 4 | Josephson Neil | ZYME | Common Stock | D | 8,0990 | -2.475 | -20 | 14.449 | ||||
| 2022-11-14 | 2022-11-10 | 4 | Josephson Neil | ZYME | Common Stock | D | 5.885 | 16.924 | ||||||
| 2022-07-05 | 2022-07-05 | 4 | Josephson Neil | ZYME | Common Shares | D | 4,5100 | 1.525 | 7 | 11.039 | ||||
| 2022-07-05 | 2022-07-05 | 4 | Klompas Neil A | ZYME | Common Shares | D | 4,5100 | 1.525 | 7 | 14.801 | ||||
| 2022-03-11 | 2022-03-10 | 4 | Josephson Neil | ZYME | Restricted Stock Unit | D | -1.666 | 3.334 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Josephson Neil | ZYME | Restricted Stock Unit | D | -729 | 730 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Josephson Neil | ZYME | Common Shares | D | 1.666 | 9.514 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Josephson Neil | ZYME | Common Shares | D | 729 | 7.848 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Astle Christopher | ZYME | Stock Option (Right to Buy) | D | 7,00 | 125.000 | 125.000 | |||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 7,00 | 200.000 | 200.000 | |||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Restricted Stock Unit | D | -2.708 | 5.417 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Restricted Stock Unit | D | -2.500 | 2.500 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Common Shares | D | 6,8800 | -2.979 | -20 | 13.276 | ||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Common Shares | D | 2.708 | 16.255 | ||||||
| 2022-03-11 | 2022-03-10 | 4 | Klompas Neil A | ZYME | Common Shares | D | 2.500 | 13.547 | ||||||
| 2022-03-04 | 3 | Astle Christopher | ZYME | Common Shares | D | 670 | ||||||||
| 2022-01-18 | 2022-01-15 | 4 | Galbraith Kenneth | ZYME | Stock Option (Right to Buy) | D | 14,97 | 500.000 | 500.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Josephson Neil | ZYME | Common Shares | D | 14,2800 | 3.600 | 51 | 7.119 | ||||
| 2022-01-11 | 2022-01-07 | 4 | Josephson Neil | ZYME | Common Shares | D | 14,2700 | 1.400 | 20 | 3.519 | ||||
| 2022-01-07 | 2022-01-07 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 13,9400 | 74 | 1 | 36.407 | ||||
| 2022-01-07 | 2022-01-07 | 4 | Josephson Neil | ZYME | Common Shares | D | 13,9400 | 65 | 1 | 2.119 | ||||
| 2022-01-07 | 2022-01-07 | 4 | Klompas Neil A | ZYME | Common Shares | D | 13,9400 | 277 | 4 | 11.047 | ||||
| 2021-11-12 | 2021-11-10 | 4 | Josephson Neil | ZYME | Restricted Stock Unit | D | 17.657 | 17.657 | ||||||
| 2021-11-12 | 2021-11-10 | 4 | Josephson Neil | ZYME | Stock Option (Right to Buy) | D | 21,18 | 105.943 | 105.943 | |||||
| 2021-09-02 | 2021-08-31 | 4 | Polverino Anthony J. | ZYME | Stock Option (Right to Buy) | D | 15,00 | -4.900 | 77.600 | |||||
| 2021-09-02 | 2021-08-31 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 15,0000 | 4.900 | 74 | 36.333 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 4,26 | -41.191 | 0 | |||||
| 2021-07-16 | 2021-07-16 | 4 | Tehrani Ali | ZYME | Common Shares | D | 36,0000 | -41.191 | -1.483 | 260.325 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Tehrani Ali | ZYME | Common Shares | D | 4,2643 | 41.191 | 176 | 301.516 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 4,27 | -3.800 | 41.191 | |||||
| 2021-07-16 | 2021-07-15 | 4 | Tehrani Ali | ZYME | Common Shares | D | 36,0000 | -3.800 | -137 | 260.325 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Tehrani Ali | ZYME | Common Shares | D | 4,2713 | 3.800 | 16 | 264.125 | ||||
| 2021-07-13 | 2021-07-12 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 4,31 | -12.669 | 44.991 | |||||
| 2021-07-13 | 2021-07-12 | 4 | Tehrani Ali | ZYME | Common Shares | D | 36,1224 | -12.669 | -458 | 260.325 | ||||
| 2021-07-13 | 2021-07-12 | 4 | Tehrani Ali | ZYME | Common Shares | D | 4,3062 | 12.669 | 55 | 272.994 | ||||
| 2021-07-08 | 2021-07-06 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 29,4900 | 510 | 15 | 6.350 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Josephson Neil | ZYME | Common Shares | D | 29,4900 | 461 | 14 | 2.054 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Klompas Neil A | ZYME | Common Shares | D | 29,4900 | 299 | 9 | 10.770 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 29,4900 | 454 | 13 | 31.433 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Priour James | ZYME | Common Shares | D | 29,4900 | 510 | 15 | 2.513 | ||||
| 2021-05-25 | 3 | Josephson Neil | ZYME | Common Shares | D | 1.593 | ||||||||
| 2021-05-07 | 2021-05-06 | 4 | RENTON HOLLINGS | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Neu Kelvin | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Cox Troy | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Mahony Susan | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Sacks Natalie | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Hillan Kenneth J. | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-05-07 | 2021-05-06 | 4 | Zoth Lota S. | ZYME | Stock Option (Right to Buy) | D | 29,49 | 9.000 | 9.000 | |||||
| 2021-04-13 | 2021-04-13 | 4 | Priour James | ZYME | Restricted Stock Unit | D | -2.266 | 4.534 | ||||||
| 2021-04-13 | 2021-04-13 | 4 | Priour James | ZYME | Common Shares | D | 27,9296 | -950 | -27 | 2.003 | ||||
| 2021-04-13 | 2021-04-13 | 4 | Priour James | ZYME | Common Shares | D | 2.266 | 2.953 | ||||||
| 2021-03-17 | 2021-03-15 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 34,24 | -837 | 94.160 | |||||
| 2021-03-17 | 2021-03-15 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 34,2400 | 837 | 29 | 5.840 | ||||
| 2021-03-17 | 2021-03-15 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 34,7200 | -786 | -27 | 5.003 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Priour James | ZYME | Restricted Stock Unit | D | 6.250 | 6.250 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Priour James | ZYME | Stock Option (Right to Buy) | D | 34,82 | 37.500 | 37.500 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Tehrani Ali | ZYME | Restricted Stock Unit | D | 25.000 | 25.000 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 34,82 | 150.000 | 150.000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Tehrani Ali | ZYME | Restricted Stock Unit | D | -7.708 | 15.417 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Tehrani Ali | ZYME | Common Shares | D | 34,9535 | -4.392 | -154 | 260.325 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Tehrani Ali | ZYME | Common Shares | D | 7.708 | 264.717 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Klompas Neil A | ZYME | Restricted Stock Unit | D | 8.125 | 8.125 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 34,82 | 48.750 | 48.750 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Klompas Neil A | ZYME | Restricted Stock Unit | D | -2.500 | 5.000 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Klompas Neil A | ZYME | Common Shares | D | 34,9535 | -1.425 | -50 | 10.471 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Klompas Neil A | ZYME | Common Shares | D | 2.500 | 11.896 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Polverino Anthony J. | ZYME | Restricted Stock Unit | D | 8.125 | 8.125 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Polverino Anthony J. | ZYME | Stock Option (Right to Buy) | D | 34,82 | 48.750 | 48.750 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Polverino Anthony J. | ZYME | Restricted Stock Unit | D | -2.500 | 5.000 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 34,9535 | -1.048 | -37 | 30.979 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 2.500 | 32.027 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | O'Driscoll Kathryn | ZYME | Restricted Stock Unit | D | 5.000 | 5.000 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 34,82 | 30.000 | 30.000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | O'Driscoll Kathryn | ZYME | Restricted Stock Unit | D | -1.354 | 2.709 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 34,9535 | -568 | -20 | 5.789 | ||||
| 2021-03-12 | 2021-03-10 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 1.354 | 6.357 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | HAUSMAN DIANA | ZYME | Restricted Stock Unit | D | 8.125 | 8.125 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 34,82 | 48.750 | 48.750 | |||||
| 2021-03-12 | 2021-03-10 | 4 | HAUSMAN DIANA | ZYME | Restricted Stock Unit | D | -2.500 | 5.000 | ||||||
| 2021-03-12 | 2021-03-10 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 34,9535 | -1.048 | -37 | 5.377 | ||||
| 2021-03-12 | 2021-03-10 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 2.500 | 6.425 | ||||||
| 2021-02-16 | 2021-02-12 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 34,24 | -2.083 | 94.997 | |||||
| 2021-02-16 | 2021-02-12 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 34,2400 | 2.083 | 71 | 5.003 | ||||
| 2021-02-03 | 3 | Priour James | ZYME | Common Shares | D | 687 | ||||||||
| 2021-01-11 | 2020-12-09 | 4/A | Klompas Neil A | ZYME | Common Shares | D | 53,2453 | -25.000 | -1.331 | 9.112 | ||||
| 2021-01-11 | 2020-12-09 | 4/A | Klompas Neil A | ZYME | Common Shares | D | 5,6708 | 16.620 | 94 | 34.112 | ||||
| 2021-01-11 | 2020-12-09 | 4/A | Klompas Neil A | ZYME | Common Shares | D | 4,1945 | 8.380 | 35 | 17.492 | ||||
| 2021-01-11 | 2021-01-08 | 4/A | Klompas Neil A | ZYME | Common Shares | D | 30,9200 | 284 | 9 | 9.396 | ||||
| 2021-01-11 | 2021-01-07 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 30,9200 | 48 | 1 | 29.527 | ||||
| 2021-01-11 | 2021-01-07 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 30,9200 | 207 | 6 | 3.925 | ||||
| 2021-01-11 | 2021-01-08 | 4 | Klompas Neil A | ZYME | Common Shares | D | 30,9200 | 284 | 9 | 9.406 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 5,67 | -16.620 | 4.330 | |||||
| 2020-12-11 | 2020-12-09 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 4,19 | -8.380 | 0 | |||||
| 2020-12-11 | 2020-12-09 | 4 | Klompas Neil A | ZYME | Common Shares | D | 53,2453 | -25.000 | -1.331 | 9.122 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Klompas Neil A | ZYME | Common Shares | D | 5,6708 | 16.620 | 94 | 34.122 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Klompas Neil A | ZYME | Common Shares | D | 4,1945 | 8.380 | 35 | 17.502 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 56,1600 | -850 | -48 | 55.511 | ||||
| 2020-12-04 | 2020-12-04 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 11,84 | -3.182 | 47.673 | |||||
| 2020-12-04 | 2020-12-04 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 9,82 | -2.850 | 68.028 | |||||
| 2020-12-04 | 2020-12-04 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 55,1187 | -6.032 | -332 | 3.718 | ||||
| 2020-12-04 | 2020-12-04 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 11,8400 | 3.182 | 38 | 9.750 | ||||
| 2020-12-04 | 2020-12-04 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 9,8200 | 2.850 | 28 | 6.568 | ||||
| 2020-12-03 | 2020-12-02 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 11,84 | -574 | 50.281 | |||||
| 2020-12-03 | 2020-12-02 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 9,82 | -127 | 70.751 | |||||
| 2020-12-03 | 2020-12-02 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 55,0114 | -701 | -39 | 3.718 | ||||
| 2020-12-03 | 2020-12-02 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 11,8400 | 574 | 7 | 4.419 | ||||
| 2020-12-03 | 2020-12-02 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 9,8200 | 127 | 1 | 3.845 | ||||
| 2020-12-03 | 2020-12-01 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 11,84 | -14.145 | 50.855 | |||||
| 2020-12-03 | 2020-12-01 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 9,82 | -4.122 | 70.878 | |||||
| 2020-12-03 | 2020-12-01 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 55,1946 | -18.267 | -1.008 | 3.718 | ||||
| 2020-12-03 | 2020-12-01 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 11,8400 | 14.145 | 167 | 21.985 | ||||
| 2020-12-03 | 2020-12-01 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 9,8200 | 4.122 | 40 | 7.840 | ||||
| 2020-11-19 | 2020-11-18 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 34,24 | -2.920 | 97.080 | |||||
| 2020-11-19 | 2020-11-18 | 4 | O'Driscoll Kathryn | ZYME | Common Shares | D | 34,2400 | 2.920 | 100 | 2.920 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 39,0354 | -3.500 | -137 | 56.361 | ||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 11,84 | -10.000 | 65.000 | |||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 15,74 | -10.000 | 65.000 | |||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 9,82 | -10.000 | 75.000 | |||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 17,15 | -10.000 | 17.235 | |||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 45,0000 | -40.000 | -1.800 | 3.718 | ||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 11,8400 | 10.000 | 118 | 43.718 | ||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 9,8200 | 10.000 | 98 | 33.718 | ||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 17,1500 | 10.000 | 172 | 23.718 | ||||
| 2020-09-16 | 2020-09-14 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 15,7400 | 10.000 | 157 | 13.718 | ||||
| 2020-07-06 | 2020-07-02 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 30,6600 | 367 | 11 | 3.718 | ||||
| 2020-07-06 | 2020-07-02 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 30,6600 | 488 | 15 | 29.479 | ||||
| 2020-07-06 | 2020-07-02 | 4 | Klompas Neil A | ZYME | Common Shares | D | 30,6600 | 277 | 8 | 9.112 | ||||
| 2020-05-12 | 2020-05-08 | 4 | BAKER BROS. ADVISORS LP See Footnotes | ZYME | Non-Qualified Stock Option (right to buy) | I | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | RENTON HOLLINGS | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | Cox Troy | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | Zoth Lota S. | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | Hillan Kenneth J. | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | Mahony Susan | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-05-12 | 2020-05-08 | 4 | Sacks Natalie | ZYME | Stock Option (Right to Buy) | D | 35,49 | 9.000 | 9.000 | |||||
| 2020-04-13 | 2020-04-13 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 3,85 | -1.000 | 57.660 | |||||
| 2020-04-13 | 2020-04-13 | 4 | Tehrani Ali | ZYME | Common Shares | D | 3,8535 | 1.000 | 4 | 257.009 | ||||
| 2020-04-07 | 2020-04-03 | 4 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 33,3899 | 80 | 3 | 59.861 | ||||
| 2020-04-07 | 2020-04-03 | 4 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 33,3903 | 495 | 17 | 59.781 | ||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 1.876.724 | ||||||||
| 2020-03-16 | 3 | BAKER JULIAN See Footnotes | ZYME | Common Stock | I | 3.248.692 | ||||||||
| 2020-03-16 | 2020-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | ZYME | Non-Qualified Stock Option (right to buy) | I | 24,28 | 18.000 | 18.000 | |||||
| 2020-03-11 | 2020-03-10 | 4 | O'Driscoll Kathryn | ZYME | Restricted Stock Unit | D | 4.063 | 4.063 | ||||||
| 2020-03-11 | 2020-03-10 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 35,20 | 24.375 | 24.375 | |||||
| 2020-03-11 | 2020-03-10 | 4 | Polverino Anthony J. | ZYME | Restricted Stock Unit | D | 7.500 | 7.500 | ||||||
| 2020-03-11 | 2020-03-10 | 4 | Polverino Anthony J. | ZYME | Stock Option (Right to Buy) | D | 35,20 | 45.000 | 45.000 | |||||
| 2020-03-11 | 2020-03-10 | 4 | HAUSMAN DIANA | ZYME | Restricted Stock Unit | D | 7.500 | 7.500 | ||||||
| 2020-03-11 | 2020-03-10 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 35,20 | 45.000 | 45.000 | |||||
| 2020-03-11 | 2020-03-10 | 4 | Tehrani Ali | ZYME | Restricted Stock Unit | D | 23.125 | 23.125 | ||||||
| 2020-03-11 | 2020-03-10 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 35,20 | 138.750 | 138.750 | |||||
| 2020-03-11 | 2020-03-10 | 4 | Klompas Neil A | ZYME | Restricted Stock Unit | D | 7.500 | 7.500 | ||||||
| 2020-03-11 | 2020-03-10 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 35,20 | 45.000 | 45.000 | |||||
| 2020-01-28 | 2020-01-27 | 4 | Cox Troy | ZYME | Common Shares | D | 46,5000 | 7.500 | 349 | 7.500 | ||||
| 2020-01-09 | 2020-01-08 | 4 | Klompas Neil A | ZYME | Common Shares | D | 19,5400 | 394 | 8 | 8.835 | ||||
| 2020-01-09 | 2020-01-08 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 19,5400 | 332 | 6 | 3.351 | ||||
| 2020-01-09 | 2020-01-08 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 19,5400 | 371 | 7 | 28.991 | ||||
| 2019-12-13 | 2019-12-12 | 4 | Polverino Anthony J. | ZYME | Stock Option (Right to Buy) | D | 15,00 | -27.500 | 82.500 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 15,0000 | 27.500 | 412 | 28.620 | ||||
| 2019-11-08 | 2019-11-08 | 4 | O'Driscoll Kathryn | ZYME | Stock Option (Right to Buy) | D | 34,24 | 100.000 | 100.000 | |||||
| 2019-07-10 | 2019-07-08 | 4 | Klompas Neil A | ZYME | Common Shares | D | 12,4900 | 464 | 6 | 8.441 | ||||
| 2019-07-10 | 2019-07-08 | 4 | Polverino Anthony J. | ZYME | Common Shares | D | 12,4900 | 1.120 | 14 | 1.120 | ||||
| 2019-07-10 | 2019-07-08 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 12,4900 | 520 | 6 | 3.019 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Bedford Nick | ZYME | Stock Option (Right to Buy) | D | 19,11 | 10.000 | 10.000 | |||||
| 2019-05-08 | 2019-05-06 | 4 | RENTON HOLLINGS | ZYME | Stock Option (Right to Buy) | D | 19,11 | 10.000 | 10.000 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Zoth Lota S. | ZYME | Stock Option (Right to Buy) | D | 19,11 | 10.000 | 10.000 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Hillan Kenneth J. | ZYME | Stock Option (Right to Buy) | D | 19,11 | 10.000 | 10.000 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Sacks Natalie | ZYME | Stock Option (Right to Buy) | D | 19,11 | 10.000 | 10.000 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 3,53 | -8.380 | 0 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 2,66 | -6.704 | 0 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Common Stock | D | 19,2506 | -1.604 | -31 | 7.977 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Common Stock | D | 3,5300 | 8.380 | 30 | 9.581 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Common Stock | D | 19,2206 | -6.704 | -129 | 1.201 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Klompas Neil A | ZYME | Common Stock | D | 2,6600 | 6.704 | 18 | 7.905 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Poon David Kai Yuen | ZYME | Stock Option (Right to Buy) | D | 3,53 | -800 | 3.390 | |||||
| 2019-05-08 | 2019-05-06 | 4 | Poon David Kai Yuen | ZYME | Common Stock | D | 19,2000 | -800 | -15 | 0 | ||||
| 2019-05-08 | 2019-05-06 | 4 | Poon David Kai Yuen | ZYME | Common Stock | D | 3,5300 | 800 | 3 | 800 | ||||
| 2019-03-29 | 2019-03-29 | 4 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 16,2400 | -3.000 | -49 | 59.286 | ||||
| 2019-03-28 | 2019-03-27 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 15,23 | 15.000 | 15.000 | |||||
| 2019-02-04 | 2019-01-31 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 16,0000 | -250.000 | -4.000 | 2.898.647 | ||||
| 2019-01-10 | 2019-01-08 | 4 | Klompas Neil A | ZYME | Stock Option (Right to Buy) | D | 15,53 | 90.000 | 90.000 | |||||
| 2019-01-10 | 2019-01-08 | 4 | Klompas Neil A | ZYME | Common Shares | D | 12,4800 | 414 | 5 | 1.201 | ||||
| 2019-01-10 | 2019-01-08 | 4 | HAUSMAN DIANA | ZYME | Stock Option (Right to Buy) | D | 15,53 | 75.000 | 75.000 | |||||
| 2019-01-10 | 2019-01-08 | 4 | HAUSMAN DIANA | ZYME | Common Shares | D | 12,4800 | 499 | 6 | 2.499 | ||||
| 2019-01-10 | 2019-01-08 | 4 | Poon David Kai Yuen | ZYME | Stock Option (Right to Buy) | D | 15,53 | 25.000 | 25.000 | |||||
| 2019-01-10 | 2019-01-08 | 4 | Polverino Anthony J. | ZYME | Stock Option (Right to Buy) | D | 15,53 | 75.000 | 75.000 | |||||
| 2019-01-10 | 2019-01-08 | 4 | Tehrani Ali | ZYME | Stock Option (Right to Buy) | D | 15,53 | 235.000 | 235.000 | |||||
| 2019-01-02 | 3 | Bedford Nick | ZYME | Common Shares | D | 274.446 | ||||||||
| 2019-01-02 | 3 | Bedford Nick | ZYME | Common Shares | D | 274.446 | ||||||||
| 2019-01-02 | 3 | Bedford Nick | ZYME | Common Shares | D | 274.446 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA Held by spouse | ZYME | Common Shares | I | 6.000 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA | ZYME | Common Shares | D | 6.000 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA Held by spouse | ZYME | Common Shares | I | 6.000 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA | ZYME | Common Shares | D | 6.000 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA Held by spouse | ZYME | Common Shares | I | 6.000 | ||||||||
| 2019-01-02 | 3 | HAUSMAN DIANA | ZYME | Common Shares | D | 6.000 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali | ZYME | Common Shares | D | 574.304 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 380.581 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali | ZYME | Common Shares | D | 574.304 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali | ZYME | Common Shares | D | 574.304 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 380.581 | ||||||||
| 2019-01-02 | 3 | Tehrani Ali Held by spouse | ZYME | Common Shares | I | 380.581 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A Held by spouse | ZYME | Common Shares | I | 2.187 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A | ZYME | Common Shares | D | 2.274 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A Held by spouse | ZYME | Common Shares | I | 2.187 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A Held by spouse | ZYME | Common Shares | I | 2.187 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A | ZYME | Common Shares | D | 2.274 | ||||||||
| 2019-01-02 | 3 | Klompas Neil A | ZYME | Common Shares | D | 2.274 | ||||||||
| 2018-11-08 | 2018-11-06 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,0000 | -700.000 | -9.800 | 3.148.647 | ||||
| 2018-09-26 | 2018-09-24 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 16,3600 | -2.027 | -33 | 3.848.647 | ||||
| 2018-09-20 | 2018-09-18 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,5600 | -6.870 | -100 | 3.850.674 | ||||
| 2018-09-18 | 2018-09-17 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,5800 | -6.865 | -100 | 3.857.544 | ||||
| 2018-09-18 | 2018-09-14 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,5800 | -9.009 | -131 | 3.864.409 | ||||
| 2018-09-14 | 2018-09-13 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,3200 | -20.900 | -299 | 3.873.418 | ||||
| 2018-09-14 | 2018-09-12 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,8300 | -10.059 | -149 | 3.894.318 | ||||
| 2018-09-12 | 2018-09-11 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,8700 | -11.277 | -168 | 3.904.377 | ||||
| 2018-09-12 | 2018-09-10 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,4400 | -4.500 | -65 | 3.915.654 | ||||
| 2018-09-04 | 2018-08-31 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,2600 | -700 | -10 | 3.920.154 | ||||
| 2018-08-31 | 2018-08-30 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,3500 | -3.440 | -49 | 3.920.854 | ||||
| 2018-08-31 | 2018-08-29 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,2600 | -2.312 | -33 | 3.924.294 | ||||
| 2018-08-16 | 2018-08-14 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,2800 | -3.000 | -43 | 3.926.606 | ||||
| 2018-08-14 | 2018-08-13 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,3300 | -4.531 | -65 | 3.929.606 | ||||
| 2018-08-14 | 2018-08-10 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 14,2800 | -1.898 | -27 | 3.934.137 | ||||
| 2018-08-07 | 2018-08-03 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 13,5500 | -1.650 | -22 | 3.936.035 | ||||
| 2018-08-03 | 2018-08-02 | 4 | LILLY ELI & CO | ZYME | Common Stock | D | 13,3100 | -19.400 | -258 | 3.937.685 | ||||
| 2018-02-14 | 3 | LILLY ELI & CO | ZYME | Common Stock | D | 7.914.170 | ||||||||
| 2018-02-14 | 3 | LILLY ELI & CO | ZYME | Common Stock | D | 7.914.170 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
